Codexis

NASDAQ: CDXS
$13.98
-$0.44 (-3.0%)
Closing price October 26, 2020
Our series on expected upside in stock prices continues today with a look at the biofuels sector. What you are about to see are numbers that, for the most part, defy gravity. With just two of these...
2011 may be off to a “Web 2.0 IPO Year” but it might just as easily be “The Year of Biofuel IPOs”… Biodiesel maker Renewable Energy Group Inc. has filed a Form S-1 for an initial public...
For about six months in 2010, Codexis, Inc. (NASDAQ: CDXS) had the publicly traded biofuels market to itself. Then Amyris, Inc. (NASDAQ: AMRS) and Gevo, Inc. (NASDAQ: GEVO) jumped in, and in May...
Alt-energy news today looks at some coming IPOs in biofuels, some comments from a hedge fund manager on clean energy, and a new design for a natural gas-fire power plant.  Biofuel maker Solazyme,...
Today’s wrap-up of alt energy news includes a look at the latest investment by Google Inc. (NASDAQ: GOOG) in wind energy, another federal loan guarantee for a solar farm, and two acquisitions in...
Solazyme, Inc. has filed a Form S-1 with the SEC announcing its plans for an IPO. This is the first filing for the company and does not include any pricing or share information. Like other biofuels...
A lot of companies are working on developing microbes to eat something ordinary and expel something extraordinary, like diesel fuel or methane or butanol. Laboratory scale projects have all proved...
Last February, Royal Dutch Shell plc (NYSE:RDS-A) and Brazil’s Cosan Ltd. (NYSE:CZZ) signed an agreement to create a joint venture to distribute and sell cane ethanol in Brazil. The two companies...
The ever-entertaining solar PV sector provides more than its share of fun today. First, Solarfun Power Holdings Co. Ltd. (NASDAQ:SOLF), a Chinese solar PV company making crystalline wafers, cells,...
Codexis, Inc. has filed its paperwork with the SEC for an initial public offering.  The company plans to trade under the ticker “CDXS” on NASDAQ.  Credit Suisse and Goldman Sachs are...
Codexis, a biocatalyst developer, submitted an SEC filing Friday evening to come public via an IPO. The offering shows a total proposed maximum price of $100 million, although this amount is for...